You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • AB0488 Influences of 2-Year Tocilizumab Therapy on Disease Activity, Quality of Life, Prevention of Joint Damage and Reduction of Concomitant Drugs (Prednisolone and Methotrexate) in Patients with Rheumatoid Arthritis

Article metrics

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Rheumatoid arthritis - other biologic treatment
AB0488 Influences of 2-Year Tocilizumab Therapy on Disease Activity, Quality of Life, Prevention of Joint Damage and Reduction of Concomitant Drugs (Prednisolone and Methotrexate) in Patients with Rheumatoid Arthritis

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 2015500
Jul 2015100
Sep 20151102
Oct 2015101
Dec 2015503
Jan 2016806
Feb 2016501
Mar 2016500
Apr 2016900
May 2016301
Jun 20161000
Jul 2016100
Aug 2016200
Sep 2016704
Oct 2016200
Nov 2016100
Dec 2016200
Jan 2017300
Mar 2017200
Apr 2017404
May 2017300
Jun 20171100
Jul 2017002
Aug 2017400
Sep 2017200
Oct 2017600
Nov 2017600
Dec 2017200
Jan 2018600
Mar 2018600
Apr 2018200
May 20184201
Jun 2018600
Jul 20181800
Aug 2018200
Sep 2018401
Oct 2018200
Nov 2018200
Feb 2019200
Mar 2019202
Apr 2019400
Jul 2019200
Nov 2019600
Jun 2020600
Jul 2020600
Aug 2020200
Sep 20201600
Oct 2020400
Nov 2020700
Dec 2020700
Jan 2021200
Feb 2021200
Aug 2021100
Oct 20211500
Nov 20211000
Dec 2021800
Jan 2022200
Feb 2022400
May 2022800
Jun 2022400
Jul 20221000
Aug 20221600
Sep 20221000
Oct 2022400
Nov 2022200
Dec 20221200
Jan 2023400
Feb 2023600
Mar 2023200
May 2023400
Jul 2023200
Aug 2023200
Sep 2023400
Dec 20231000
Jan 2024200
Feb 2024200
Mar 2024200
Total425028